On ECHEMI

PolyPeptide Laboratories GmbH

Germany
Favorite Supplier
 353 people visit

Product List

Product Name Synonyms CAS No. Grate/Content Operate

(BOC-AMINOOXY)ACETIC ACID

BOC-(NHOAC)-OH;BOC-NH-O-CH2COOH;BOC-AOA;BOC-AOAC-OH;BOC-AOA-OH;(BOC-AMINOOXY)ACETIC ACID;BOC-3-(AMINOOXY)ACETIC ACID;2-(BOC-AMINOOXY)-ACETIC ACID
42989-85-5 Inquiry

(LEU31,PRO34)-NEUROPEPTIDE Y (HUMAN, RAT)

132699-73-1 Inquiry

(NLE27)-GRF (1-29) AMIDE (HUMAN)

(Nle27)-SerMorelin;(NLE27)-GRF (1-29) AMIDE (HUMAN);somatotropin (1-29)amide, Nle(27)-;somatoliberin fragment 1-29 amide [Nleu27], human;(Nle27)-GRF (1-29) aMide (huMan)(Nle27)-SerMorelin;(NLE27)-GROWTH HORMONE RELEASING FACTOR FRAGMENT 1-;(NLE27)-GROWTH HORMONE-RELEASING FACTOR (1-29) AMIDE (HUMAN);[Nle27]-Growth Hormone Releasing Factor Human fragment 1-29 amide;(NLE27)-GROWTH HORMONE RELEASING FACTOR FRAGMENT 1-29 AMIDE HUMAN);H-TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-
91869-58-8 Inquiry

AC-ARG-ARG-PRO-TYR-ILE-LEU-OH

AC-RRPYIL;AC-NEUROTENSIN (8-13);ACETYL-NEUROTENSIN (8-13);AC-ARG-ARG-PRO-TYR-ILE-LEU;AC-ARG-ARG-PRO-TYR-ILE-LEU-OH;N-ACETYL-NEUROTENSIN, 8-13;NEUROTENSIN (8-13), N-ACETYL;na-ac-neurotensin fragment 8-13
74853-69-3 Inquiry

ACTH (34-39)

ACTH (34-39);AFPLEF-OH;69454-10-0;H-Ala-Phe-Pro-Leu-Glu-Phe-OH;HY-P1739;ZINC97972728;CS-0095089;(4S)-4-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-Aminopropanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(1S)-1-carboxy-2-phenylethyl]amino]-5-oxopentanoic acid
69454-10-0 Inquiry

ALA-CYS-ASP-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2

CGRPI;CGRP (HUMAN);CGRP-1, HUMAN;CGRP-I, HUMAN;a-CGRP (huMan);ALPHA-CGRP (HUMAN);α-CGRP (huMan)CGRP-I (huMan);M.W. 3789.36 C163H267N51O49S2;CGRP-I (HUMAN) TRIFLUOROACETATE SALT;CALCITONIN GENE RELATED PEPTIDE HUMAN
90954-53-3 Inquiry

ALPHA-CGRP (RAT)

H-SER-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASP-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-GLU-ALA-PHE-NH2 (DISULFIDE BRIDGE: 2-7);CGRP (RAT);SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (DISULFIDE BRIDGE: 2-7);SER-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-GLY-LEU-LEU-SER-ARG-SER-GLY-GLY-VAL-VAL-LYS-ASP-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-GLU-ALA-PHE-NH2;calcitonin gene-rel. peptide;A-CGRP (RAT);calcitonin gene-regulated peptide, cyclic disulfide, rat;α-CGRP (mouse, rat)
83651-90-5 Inquiry

ALPHA-HELICAL CRF (9-41)

CORTICOTROPIN RELEASING FACTOR ANTAGONIST;H-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-MET-LEU-GLU-MET-ALA-LYS-ALA-GLU-GLN-GLU-ALA-GLU-GLN-ALA-ALA-LEU-ASN-ARG-LEU-LEU-LEU-GLU-GLU-ALA-NH2;ASP-LEU-THR-PHE-HIS-LEU-ARG-GLU-MET-LEU-GLU-MET-ALA-LYS-ALA-GLU-GLN-ALA-GLU-GLN-ALA-LEU-ASN-ARG-LEU-LEU-GLU-ALA-NH2;ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-MET-LEU-GLU-MET-ALA-LYS-ALA-GLU-GLN-GLU-ALA-GLU-GLN-ALA-ALA-LEU-ASN-ARG-LEU-LEU-LEU-GLU-GLU-ALA-NH2;ALPHA-HELICAL CORTICOTROPIN RELEASING FA CTOR;α-helical corticotropin releasing factor fragment (9-41);alpha-Helical corticotropin releasing factor fragment;ALPHA-HELICAL CORTICOTROPIN RELEASING FACTOR (9-41)
99658-03-4 Inquiry

ALPHA-MSH

a-MSH;C02758;ALPHA-MSH;-MSH;ALPHA-MSH,AMIDE;ALPHA-MSN,HUMAN;alpha-Intermedin;ALPHA-MELANOTROPIN;α-Melanotropin【pig】;AC-SYSMEHFRWGKPV-NH2
581-05-5 Inquiry

AMYLIN (8-37) (HUMAN)

ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2;H-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2;AMYLIN (8-37) (HUMAN);AMYLIN FRAGMENT 8-37 HUMAN;amylin fragment 8-37 amide;diabetes associated peptide fragment 8-37 amide;Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2;Human amylin 8-37
135702-23-7 Inquiry

ANGIOTENSIN II, HUMAN

AngII;DRVYIHPF;TY-10721;ANGIOTENSIN-2;ANGIOTENSINII;ANTI-ANGIOTENSINII;ile(5)-angiotensini;[ILE5]-ANGIOTENSIN2;angiotensinii(mouse);[Ile5]angiotensinII
4474-91-3 Inquiry

ANTISAUVAGINE-30

D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2;(D-PHE11,HIS12)-SAUVAGINE (11-40);(D-PHE11,HIS12)-SAUVAGINE (11-40) TRIFLUOROACETATE SALT;H-D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THE-ILE-OH;H-D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2;ANTISAUVAGINE-30;M.W. 3650.29C161H274N48O46S;11-D-Phenylalanine-12-L-histidine-11-40-sauvagin
220673-95-0 Inquiry

ASP-LEU-SER-LYS-GLN-MET-GLU-GLU-GLU-ALA-VAL-ARG-LEU-PHE-ILE-GLU-TRP-LEU-LYS-ASN-GLY-GLY-PRO-SER-SER-GLY-ALA-PRO-PRO-PRO-SER-NH2

ASP-LEU-SER-LYS-GLN-MET-GLU-GLU-GLU-ALA-VAL-ARG-LEU-PHE-ILE-GLU-TRP-LEU-LYS-ASN-GLY-GLY-PRO-SER-SER-GLY-ALA-PRO-PRO-PRO-SER-NH2;H-ASP-LEU-SER-LYS-GLN-MET-GLU-GLU-GLU-ALA-VAL-ARG-LEU-PHE-ILE-GLU-TRP-LEU-LYS-ASN-GLY-GLY-PRO-SER-SER-GLY-ALA-PRO-PRO-PRO-SER-NH2;EXENDIN 3 (9-39);EXENDIN-3 (9-39) AMIDE;EXENDIN (9-39);EXENDIN (9-39) AMIDE;EXENDIN [9-39] PEPTIDE;EXENDIN FRAGMENT 9-39
133514-43-9 Inquiry

ATRIAL NATRIURETIC FACTOR (1-28) (RAT)

H-SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR-OH (DISULFIDE BRIDGE: 7-23);ATRIAL NATRIURETIC PEPTIDE (1-28), RAT;ATRIAL NATRIURETIC PEPTIDE;ATRIAL NATRIURETIC FACTOR (1-28) (RAT);A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 1-28) (RABBIT, MOUSE);ATRIAL NATRIURETIC PEPTIDE, RAT;CARDIONATRIN;RANF
88898-17-3 Inquiry

BETA-MSH, HUMAN

AEKKDEGPYRMEHFRWGSPPKD;ALA-GLU-LYS-LYS-ASP-GLU-GLY-PRO-TYR-ARG-MET-GLU-HIS-PHE-ARG-TRP-GLY-SER-PRO-PRO-LYS-ASP;MELANOCYTE STIMULATING HORMONE, BETA-HUMAN;H-ALA-GLU-LYS-LYS-ASP-GLU-GLY-PRO-TYR-ARG-MET-GLU-HIS-PHE-ARG-TRP-GLY-SER-PRO-PRO-LYS-ASP-OH;BETA-MSH (1-22) (HUMAN);BETA-MSH, HUMAN;BETA-MSH, HUMAN TFA;BETA-MELANOCYTE STIMULATING HORMONE (1-22) (HUMAN)
17908-57-5 Inquiry

BIOTINYL-NEUROPEPTIDE Y (HUMAN, RAT)

BIOTIN-TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;BIOTINYL-TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;BIOTIN-YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2;BIOTINYL-NEUROPEPTIDE Y (HUMAN, RAT);BIOTINYL-NPY (HUMAN, RAT);NEUROPEPTIDE Y, BIOTINYLATED, HUMAN;Biotinyl-Neuropeptide Y (huMan, rat)Biotinyl-NPY (huMan, rat);N-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]neuropeptide Y (human)
213779-13-6 Inquiry

BIS-BOC-AMINO-OXYACETIC ACID

BIS-BOC-AMINO-OXYACETIC ACID;BOC-AOA-OH;Bis-Boc-Aoa;BOC-AOA-OH Bis-Boc-aMinooxyacetic acid;Bis-Boc-AOA-OHBis-Boc-aMinooxyacetic acid;2-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]oxyacetic acid;Bis-Boc-amino-oxyacetic acid monohydrate≥ 98% (HPLC);Bis-Boc-Aoa H2O
293302-31-5 Inquiry

BOC-6-AMINOHEXANOIC ACID

Hexanoic acid,6-[[(1,1-dimethylethoxy)carbonyl]amino]-;Hexanoic acid,6-(carboxyamino)-,N-tert-butyl ester;Hexanoic acid,6-(carboxyamino)-,6-tert-butyl ester;6-[[(1,1-Dimethylethoxy)carbonyl]amino]hexanoic acid;N-(tert-Butyloxycarbonyl)-ε-aminocaproic acid;N-(tert-Butoxycarbonyl)-6-aminohexanoic acid;N-(tert-Butoxycarbonyl)-ε-aminohexanoic acid;tert-Butoxycarbonyl-ε-aminocaproic acid;N-(tert-Butoxycarbonyl)-ε-aminocaproic acid;N-(tert-Butoxycarbonyl)-6-aminocaproic acid;BOC-ε-aminocaproic acid;6-[N-(tert-Butoxycarbonyl)amino]caproic acid;N-Boc-aminohexanoic acid;6-(tert-Butoxycarbonylamino)caproic acid;Boc-6-aminohexanoic acid;6-[(tert-Butoxycarbonyl)amino]hexanoic acid;1-tert-Butoxycarbonylamino-6-hexanoic acid;N-BOC-6-aminocaproic acid;1260612-19-8
6404-29-1 Inquiry

Bombesin

2-l-glutamine-6-l-asparagine-alytesi;bombesin acetate;Bombesin, Free Base;BOMBESIN SYNTHETIC >97% STIMULATES GASTR IN RE;Bombesinhydrateacetatesalt;M.W. 1619.85C71H110N24O18S;5-Oxo-L-Pro-L-Gln-L-Arg-L-Leu-Gly-L-Asn-L-Gln-L-Trp-L-Ala-L-Val-Gly-L-His-L-Leu-L-Met-NH2;Bombesin acetate salt hydrate
31362-50-2 Inquiry

BRADYKININ

bk;brs640;prs640;C00306;RPPGFSPFR;BRADYZIDE;Callideic;KallidinⅠ;BRADYKININ;CallidinI
58-82-2 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

China

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.